481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors

481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors

Bibliographic Details
Main Authors: Michael Manos, Patrick Ott, Anita Giobbie-Hurder, Osama Rahma, Nicole LeBoeuf, Kevin Tyan, Ai-Tram Bui, Isaac Klein, Leyre Zubiri, Kerry Reynolds, Shilpa Grover, Gerald Weinhouse
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-e6d1e8ed5c5b48779a6fe8130c0bd37a
record_format Article
spelling doaj-e6d1e8ed5c5b48779a6fe8130c0bd37a2020-12-11T10:02:18ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0481481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint InhibitorsMichael Manos0Patrick Ott1Anita Giobbie-Hurder2Osama Rahma3Nicole LeBoeuf4Kevin Tyan5Ai-Tram Bui6Isaac Klein7Leyre Zubiri8Kerry Reynolds9Shilpa Grover10Gerald Weinhouse112Dana-Farber Cancer Institute, Boston, MA, USA2Dana-Farber Cancer Institute, Boston, MA, USA2Dana-Farber Cancer Institute, Boston, MA, USA2Dana-Farber Cancer Institute, Boston, MA, USA4Brigham and Women’s Hospital, Bostom, MA, USA1Harvard Medical School, Somerville, MA, USA1Harvard Medical School, Somerville, MA, USA2Dana-Farber Cancer Institute, Boston, MA, USA3Massachusetts General Hospital, Boston, MA, USA3Massachusetts General Hospital, Boston, MA, USA4Brigham and Women’s Hospital, Bostom, MA, USA4Brigham and Women’s Hospital, Bostom, MA, USA
collection DOAJ
language English
format Article
sources DOAJ
author Michael Manos
Patrick Ott
Anita Giobbie-Hurder
Osama Rahma
Nicole LeBoeuf
Kevin Tyan
Ai-Tram Bui
Isaac Klein
Leyre Zubiri
Kerry Reynolds
Shilpa Grover
Gerald Weinhouse
spellingShingle Michael Manos
Patrick Ott
Anita Giobbie-Hurder
Osama Rahma
Nicole LeBoeuf
Kevin Tyan
Ai-Tram Bui
Isaac Klein
Leyre Zubiri
Kerry Reynolds
Shilpa Grover
Gerald Weinhouse
481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors
Journal for ImmunoTherapy of Cancer
author_facet Michael Manos
Patrick Ott
Anita Giobbie-Hurder
Osama Rahma
Nicole LeBoeuf
Kevin Tyan
Ai-Tram Bui
Isaac Klein
Leyre Zubiri
Kerry Reynolds
Shilpa Grover
Gerald Weinhouse
author_sort Michael Manos
title 481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors
title_short 481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors
title_full 481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors
title_fullStr 481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors
title_full_unstemmed 481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors
title_sort 481 impact of covid-19 on cancer patients receiving immune checkpoint inhibitors
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT michaelmanos 481impactofcovid19oncancerpatientsreceivingimmunecheckpointinhibitors
AT patrickott 481impactofcovid19oncancerpatientsreceivingimmunecheckpointinhibitors
AT anitagiobbiehurder 481impactofcovid19oncancerpatientsreceivingimmunecheckpointinhibitors
AT osamarahma 481impactofcovid19oncancerpatientsreceivingimmunecheckpointinhibitors
AT nicoleleboeuf 481impactofcovid19oncancerpatientsreceivingimmunecheckpointinhibitors
AT kevintyan 481impactofcovid19oncancerpatientsreceivingimmunecheckpointinhibitors
AT aitrambui 481impactofcovid19oncancerpatientsreceivingimmunecheckpointinhibitors
AT isaacklein 481impactofcovid19oncancerpatientsreceivingimmunecheckpointinhibitors
AT leyrezubiri 481impactofcovid19oncancerpatientsreceivingimmunecheckpointinhibitors
AT kerryreynolds 481impactofcovid19oncancerpatientsreceivingimmunecheckpointinhibitors
AT shilpagrover 481impactofcovid19oncancerpatientsreceivingimmunecheckpointinhibitors
AT geraldweinhouse 481impactofcovid19oncancerpatientsreceivingimmunecheckpointinhibitors
_version_ 1724386619022114816

Similar Items